Datla, K P <br/><br/>
Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions.  [electronic resource] 

 -  Movement disorders : official journal of the Movement Disorder Society  May 2001 
 - 424-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0885-3185 
<br/><br/><label>Standard No.: </label>10.1002/mds.1091  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic Agents--pharmacology<br/>Analysis of Variance<br/>Animals<br/>Antiparkinson Agents--administration & dosage<br/>Benserazide--administration & dosage<br/>Chlorides<br/>Chromatography, High Pressure Liquid<br/>Disease Models, Animal<br/>Dopamine--metabolism<br/>Dopamine Agents--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Ferric Compounds--pharmacology<br/>Immunoenzyme Techniques<br/>Levodopa--administration & dosage<br/>Male<br/>Neostriatum--drug effects<br/>Nerve Net<br/>Neurons--drug effects<br/>Neuroprotective Agents--administration & dosage<br/>Oxidopamine--pharmacology<br/>Parkinson Disease--drug therapy<br/>Parkinson Disease, Secondary--chemically induced<br/>Rats<br/>Rats, Sprague-Dawley<br/>Substantia Nigra--drug effects<br/>Tyrosine 3-Monooxygenase--analysis